53 related articles for article (PubMed ID: 3024081)
1. Neurotoxicity of endosulfan in young and adult rats.
Seth PK; Saidi NF; Agrawal AK; Anand M
Neurotoxicology; 1986; 7(2):623-35. PubMed ID: 3024081
[No Abstract] [Full Text] [Related]
2. Neonatal endosulfan neurotoxicity: behavioral and biochemical changes in rat pups.
Zaidi NF; Agrawal AK; Anand M; Seth PK
Neurobehav Toxicol Teratol; 1985; 7(5):439-42. PubMed ID: 4080062
[TBL] [Abstract][Full Text] [Related]
3. Involvement of serotonergic receptors in endosulfan neurotoxicity.
Agrawal AK; Anand M; Zaidi NF; Seth PK
Biochem Pharmacol; 1983 Dec; 32(23):3591-3. PubMed ID: 6686038
[TBL] [Abstract][Full Text] [Related]
4. The effect of GYKI-32 887 on dopamine (D2) and serotonin (5-HT1 and 5-HT2) receptors.
Berzétei IP; Bagdy E; Hardy M; Borsy J
Pol J Pharmacol Pharm; 1985; 37(3):237-42. PubMed ID: 4070077
[TBL] [Abstract][Full Text] [Related]
5. Brain neurotransmitter receptor alterations in offspring of rats exposed to phenobarbital, phenytoin or their combination during pregnancy.
Seth PK; Alleva FR; Takagi S; Yen-Koo HC; Balazs T
Neurotoxicology; 1987; 8(1):45-53. PubMed ID: 3031564
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
Bacopoulos NG
J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
[TBL] [Abstract][Full Text] [Related]
7. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
Akiyama K; Sato M; Kashihara K; Otsuki S
Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
[TBL] [Abstract][Full Text] [Related]
8. Effect of pyridoxine deficiency in young rats on high-affinity serotonin and dopamine receptors.
Paulose CS; Dakshinamurti K
J Neurosci Res; 1985; 14(2):263-70. PubMed ID: 4046074
[TBL] [Abstract][Full Text] [Related]
9. Effects of D-5-hydroxytryptophan and D-DOPA on binding at serotonin and dopamine receptors.
Acton G
Res Commun Chem Pathol Pharmacol; 1988 Apr; 60(1):129-32. PubMed ID: 3132733
[TBL] [Abstract][Full Text] [Related]
10. [Role of serotonin and dopamine receptors in the mechanism of action of haloperidol and pirenperone].
Maĭmets MO; Vasar EE; Nurk AM; Allikmets LKh
Farmakol Toksikol; 1985; 48(2):15-8. PubMed ID: 3996566
[TBL] [Abstract][Full Text] [Related]
11. Caerulein stimulates [3H]-spiperone binding in vivo after long-term haloperidol administration.
Vasar E; Maimets M; Nurk A; Allikmets L
Psychopharmacol Bull; 1984; 20(4):691-2. PubMed ID: 6494396
[No Abstract] [Full Text] [Related]
12. Neurotransmitters and neurotransmitter receptors in developing and adult rats during manganese poisoning.
Seth PK; Chandra SV
Neurotoxicology; 1984; 5(1):67-76. PubMed ID: 6144084
[TBL] [Abstract][Full Text] [Related]
13. Some aspects of the dopaminergic action of ergot derivatives and their role in the treatment of migraine.
Horowski R
Adv Neurol; 1982; 33():325-34. PubMed ID: 7055013
[No Abstract] [Full Text] [Related]
14. An assessment of the developmental, reproductive, and neurotoxicity of endosulfan.
Silva MH; Gammon D
Birth Defects Res B Dev Reprod Toxicol; 2009 Feb; 86(1):1-28. PubMed ID: 19243027
[TBL] [Abstract][Full Text] [Related]
15. 5-HT and DA receptor affinity of arylpiperazine derivatives with terminal benzamide fragment.
Perrone R; Berardi F; Leopoldo M; Tortorella V; Lograno MD; Daniele E; Govoni S
Farmaco; 1994 Sep; 49(9):567-72. PubMed ID: 7811352
[TBL] [Abstract][Full Text] [Related]
16. [Hallucinogen caused motility disorders in rats as potential psychosis relevant animal model].
Oelssner W
Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():53-60. PubMed ID: 7157125
[No Abstract] [Full Text] [Related]
17. [Effect of long-term neuroleptic administration on CNS receptors plasticity].
Allikmets LKh; Zharkovskiĭ AM; Nurk AM; Vasar EE; Maĭmets MO
Vestn Akad Med Nauk SSSR; 1984; (11):37-42. PubMed ID: 6152099
[No Abstract] [Full Text] [Related]
18. Drug-induced alterations in neurotransmitter receptor binding and function.
Enna SJ; Ferkany JW; Strong R
Adv Biochem Psychopharmacol; 1980; 21():253-63. PubMed ID: 6246740
[No Abstract] [Full Text] [Related]
19. Detection of multiple receptors for dopamine.
Spano PF; Memo M; Stefanini E; Fresia P; Trabucchi M
Adv Biochem Psychopharmacol; 1980; 21():243-51. PubMed ID: 7376971
[No Abstract] [Full Text] [Related]
20. Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides.
Fuxe K; Agnati LF; Benfenati F; Celani M; Zini I; Zoli M; Mutt V
J Neural Transm Suppl; 1983; 18():165-79. PubMed ID: 6192208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
